CIK Cells and HDAC Inhibitors in Multiple Myeloma

Author： Stephan David   Weiher Hans   Schmidt-Wolf Ingo G.H.  

Publisher： MDPI

E-ISSN： 1422-0067|18|5|945-945

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.18, Iss.5, 2017-04, pp. : 945-945

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma

By Ribatti Domenico  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1225-1231

MDPI

Access to resources Recommend Favorite

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

By Merin Noah M.   Kelly Kevin R.  

Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. : 1-20

MDPI

Access to resources Recommend Favorite

HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells

By Chen Yun   Tsai Ya-Hui   Tseng Sheng-Hong  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 258-258

MDPI

Access to resources Recommend Favorite

Innovative Clinical Perspectives for CIK Cells in Cancer Patients

By Introna Martino   Correnti Fabio  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 358-358

MDPI

Access to resources Recommend Favorite

Histone Deacetylase (HDAC) Inhibitors Down-Regulate Endothelial Lineage Commitment of Umbilical Cord Blood Derived Endothelial Progenitor Cells

By Iordache Florin   Buzila Cosmin   Constantinescu Andrei   Andrei Eugen   Maniu Horia  

International Journal of Molecular Sciences, Vol. 13, Iss. 11, 2012-11 ,pp. : 15074-15085

MDPI

Access to resources Recommend Favorite